Instituto Universitario de Investigación en Neuroquímica
Centro/Instituto
JOSÉ ANTONIO
MARTÍNEZ ORGADO
Profesor asociado de Ciencias de la Salud
Publicaciones en las que colabora con JOSÉ ANTONIO MARTÍNEZ ORGADO (17)
2018
-
Cannabinoid signalling in the immature brain: Encephalopathies and neurodevelopmental disorders
Biochemical Pharmacology, Vol. 157, pp. 85-96
2015
-
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications
Neurotherapeutics, Vol. 12, Núm. 4, pp. 793-806
2014
-
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
Epilepsia, Vol. 55, Núm. 6, pp. 791-802
2013
-
Cannabidiol for neurodegenerative disorders: Important new clinical applications for this phytocannabinoid?
British Journal of Clinical Pharmacology, Vol. 75, Núm. 2, pp. 323-333
-
Cannabinoids: Well-Suited candidates for the treatment of perinatal brain injury
Brain Sciences, Vol. 3, Núm. 3, pp. 1043-1059
2012
-
Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function
Neuropharmacology, Vol. 63, Núm. 5, pp. 776-783
2010
-
The cannabinoid WIN55212-2 promotes neural repair after neonatal hypoxia-ischemia
Stroke, Vol. 41, Núm. 12, pp. 2956-2964
-
The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB2 and adenosine receptors
Neurobiology of Disease, Vol. 37, Núm. 2, pp. 434-440
2007
-
The cannabinoid agonist WIN55212 reduces brain damage in an in vivo model of hypoxic-ischemic encephalopathy in newborn rats
Pediatric Research, Vol. 62, Núm. 3, pp. 255-260
-
The seek of neuroprotection: Introducing cannabinoids
Recent Patents on CNS Drug Discovery, Vol. 2, Núm. 2, pp. 131-139
2006
-
Characterization of the neuroprotective effect of the cannabinoid agonist WIN-55212 in an in vitro model of hypoxic-ischemic brain damage in newborn rats
Pediatric Research, Vol. 60, Núm. 2, pp. 169-173
-
Nitric oxide synthase as a target for the prevention of hypoxic-ischemic newborn brain damage
Current Enzyme Inhibition, Vol. 2, Núm. 3, pp. 219-229
2005
-
El sistema cannabinoide y su importancia en el período perinatal
Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 63, Núm. 5, pp. 433-440
-
Immature rat brain slices exposed to oxygen-glucose deprivation as an in vitro model of neonatal hypoxic-ischemic encephalopathy
Journal of Neuroscience Methods, Vol. 145, Núm. 1-2, pp. 205-212
-
Neuroprotective effect of L-arginine in a newborn rat model of acute severe asphyxia
Biology of the Neonate, Vol. 88, Núm. 4, pp. 291-298
-
Perinatal asphyxia: Neonatal considerations
Proceedings of the 7th World Congress of Perinatal Medicine
-
The cannabinoid system and its importance in the perinatal period
Anales de Pediatria, Vol. 63, Núm. 5, pp. 433-440